Instil Bio, Inc.
TILNasdaqCIK 1789769HealthcareFiscal year ends Dec 31
Reports and events: 101 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-1317:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-23-000090 |
| 2023-08-1407:05 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001789769-23-000085 |
| 2023-08-1407:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-23-000083 |
| 2023-06-2616:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001789769-23-000077 |
| 2023-06-1416:31 ET | 8-K | 5.07 Shareholder vote results | 0001789769-23-000073 |
| 2023-05-1107:09 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001789769-23-000069 |
| 2023-05-1107:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-23-000067 |
| 2023-04-2416:30 ET | DEF 14A | Proxy statementPeriod 2023-06-14 | 0001789769-23-000048 |
| 2023-03-3107:38 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001789769-23-000035 |
| 2023-03-3107:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-23-000033 |
| 2023-03-1015:47 ET | 8-K | 8.01 Other events | 0001789769-23-000027 |
| 2023-02-2717:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001789769-23-000025 |
| 2023-02-0117:01 ET | 8-K | 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001789769-23-000020 |
| 2023-01-2717:00 ET | 8-K | 3.01 Delisting notice | 0001789769-23-000018 |
| 2023-01-0916:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001789769-23-000004 |
| 2022-12-0817:00 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001789769-22-000102 |
| 2022-11-1416:17 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001789769-22-000098 |
| 2022-11-1416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-22-000096 |
| 2022-11-0816:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001789769-22-000090 |
| 2022-10-3107:24 ET | 8-K | 8.01 Other events | 0001193125-22-273131 |
| 2022-10-1817:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001789769-22-000087 |
| 2022-09-0617:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001789769-22-000077 |
| 2022-08-1207:23 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001789769-22-000069 |
| 2022-08-1207:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-22-000067 |
| 2022-06-1317:08 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001789769-22-000063 |
| 2022-05-2717:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001789769-22-000058 |
| 2022-05-2017:08 ET | 8-K | 5.07 Shareholder vote results | 0001789769-22-000043 |
| 2022-05-1817:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001789769-22-000039 |
| 2022-05-1607:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-22-000035 |
| 2022-05-1607:03 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001789769-22-000032 |
| 2022-03-3016:20 ET | DEF 14A | Proxy statementPeriod 2022-05-20 | 0001789769-22-000021 |
| 2022-03-0707:14 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001789769-22-000008 |
| 2022-03-0707:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-22-000006 |
| 2021-12-1717:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001789769-21-000072 |
| 2021-11-1507:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001789769-21-000069 |
| 2021-11-1507:16 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001789769-21-000067 |
| 2021-11-1507:10 ET | 8-K | 9.01 Financial statements and exhibits | 0001789769-21-000065 |
| 2021-09-1607:11 ET | 8-K | 8.01 Other events | 0001789769-21-000061 |
| 2021-09-1316:02 ET | 8-K | 8.01 Other events | 0001789769-21-000055 |
| 2021-08-1216:04 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001789769-21-000052 |
| 2021-08-1216:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-21-000050 |
| 2021-05-1316:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-21-000029 |
| 2021-05-1316:38 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001789769-21-000027 |
| 2021-04-2717:23 ET | 8-K | 8.01 Other events | 0001789769-21-000018 |
| 2021-04-1316:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001789769-21-000009 |
| 2021-04-0517:27 ET | SC 13D | Ownership report, active investor | 0001193125-21-106525 |
| 2021-04-0116:15 ET | SC 13D | Ownership report, active investor | 0001140361-21-011240 |
| 2021-03-2316:22 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-21-091216 |
| 2021-03-1808:53 ET | S-1/A | Registration statement, amended | 0001193125-21-085124 |
| 2021-03-1506:56 ET | S-1/A | Registration statement, amended | 0001193125-21-080468 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.